Flowable, a global player in intelligent automation and enterprise transformation, is heading to Barcelona for the Gartner IT Symposium/Xpo™ 2025, running November 10–13 at the Centre de Convencions Internacional de Barcelona (CCIB). The company will showcase its platform’s ability to unify workflows, orchestrate AI agents, and balance agility with compliance in complex enterprise operations at Booth 301.
Ryght AI, the platform redefining clinical trial execution with its AI Site Twin technology, is set to take center stage at HLTH 2025 in Las Vegas. From October 19–22, healthcare leaders, sponsors, and CROs can see live demonstrations of the platform at the Microsoft Booth (#3860, Level 2, AI Zone).
Generative AI Solutions Corp. (CSE: AICO, OTCQB: AICOF) is in the middle of a high-stakes accounting shuffle. The company announced that its former auditor, Manning Elliott LLP, resigned effective September 29, 2025, and withdrew its May 2024 audit report on GenAI’s 2024 financial statements. The withdrawal effectively nullifies the previously issued audit, leaving investors without a vetted picture of the company’s finances.
Ataraxis AI, a developer of AI-powered prognostic tools for oncology, has announced a strategic collaboration with MEDSIR, a global leader in oncology research, to integrate artificial intelligence into multiple major international clinical trials. The studies will analyze data from over 1,000 patients, aiming to identify biomarkers that optimize treatment strategies for breast cancer, including CDK4/6 inhibitors and antibody-drug conjugates (ADCs).
Hightouch, a leading data and AI agent platform for marketers, has appointed Akilesh Bapu, co-founder and former CEO of healthcare AI startup Deepscribe, as Head of AI Product Development. Bapu, a Forbes 30 under 30 honoree, brings extensive experience building AI platforms that scale, having led Deepscribe’s growth through multiple funding rounds and partnerships with major health systems.
